FDA approves new blood test for Alzheimer’s disease
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer's disease, marking the fourth time such a blood test has been approved in less than two years.
Roche announced on Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease.
It's the fourth...
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on thehill.com — the content belongs to The Hill.
